Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Alector Inc ALEC

Healthcare Biotechnology
Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases. The company’s products under development include Latozinemab (AL001), an investigational human recombinant monoclonal antibody designed to elevate progranulin (PGRN), a protein encoded by the granulin (GRN) gene that regulates... see more

Current News (NDAQ:ALEC)

Levi & Korsinsky Announces an Investigation on Behalf of Alector, Inc. (ALEC) Shareholders Who May Have Been Affected by Fraud

ACCESS Newswire January 8, 2026

Alector, Inc. (ALEC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

ACCESS Newswire January 6, 2026

ALEC ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alector, Inc.

ACCESS Newswire December 31, 2025

Investors who lost money on Alector, Inc. should contact Levi & Korsinsky about an ongoing investigation - ALEC

ACCESS Newswire December 30, 2025

Alector, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - ALEC

ACCESS Newswire December 29, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Alector, Inc. (ALEC) Regarding Possible Securities Fraud Violations

ACCESS Newswire December 26, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Alector, Inc. (ALEC) Regarding Possible Securities Fraud Violations

ACCESS Newswire December 23, 2025

Alector, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALEC

ACCESS Newswire December 22, 2025

Shareholders that lost money on Alector, Inc.(ALEC) should contact Levi & Korsinsky about Securities Fraud Investigation - ALEC

ACCESS Newswire December 19, 2025
View More News ››

Opinion & Analysis (NDAQ:ALEC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALEC)

Be the first to post on this bullboard.

Stallion Uranium Corp.

Stallion Uranium Corp.

Stallion Uranium Corp. engages in the acquisition and exploration of mineral property assets in the United States and Canada. ...
View More »

Podcasts